OrphoMed
ClosedBay Area, United States · Founded 2015 · $41.8M raised
- Headquarters
- Bay Area, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Total Funding
- $41.8M
- Last Round
- $39.0M Series AMay 2017
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
OrphoMed is a clinical-stage biopharmaceutical company based in San Francisco, California focused on developing novel first-in-class dimer therapeutics. The company's pipeline targets gastrointestinal conditions including irritable bowel syndrome with diarrhea and opioid bowel dysfunction. OrphoMed received FDA Fast Track designation for its lead compound ORP-101 and reported positive Phase 2 results in 2022.
Summary
OrphoMed is a Biotech company based in Bay Area, United States, founded in 2015. It has raised $41.8M in total across 2 rounds, most recently a $39.0M Series A round in May 2017. Investors include New Enterprise Associates, Takeda (JP) and Pappas Capital.
Funding History
May 2017
Sign up to see all 2 events
Funding: Convertible Note through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/orphomed"><img src="https://indexed.vc/api/badge/company/orphomed" alt="OrphoMed on Indexed.vc" width="260" height="76" /></a>